Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5717-5724

  Wise, Robert P ^a   Bonhoeffer, Jan ^b   Beeler, Judy ^a   Donato, Hugo ^d   Downie, Peter ^e   Matthews, Dana ^f   Pool, Vitali ^g   Riise Bergsaker, Marianne ^h   Tapiainen, Terhi ^b,c   Varricchio, Frederick ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF OULU   (Finland)

^d Hospital Municipal del Niño   (Argentina)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f UNIVERSITY OF WASHINGTON   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Adverse event; Case definition; Guidelines; Immunization; Thrombocytopenia

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; SMALLPOX VACCINE; VACCINE;

ARTICLE; BACTERIAL INFECTION; CASE DEFINITION; CASE STUDY; CHICKENPOX; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA ANALYSIS; DECISION MAKING; DIPHTHERIA; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HAEMOPHILUS INFLUENZAE TYPE B; HEMATOLOGICAL PARAMETERS; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFLUENZA; MEASLES; MUMPS; OUTCOMES RESEARCH; PERTUSSIS; POLIOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RABIES; RUBELLA; SIDE EFFECT; SMALLPOX; STANDARD; TETANUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS INFECTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNIZATION; SAFETY; TERMINOLOGY; THROMBOCYTOPENIA;

EID: 34447315869     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.067     Document Type: Article

References (53)

1. Bussel J., and Cines D. Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia and posttransfusion purpura. In: Hoffman R. (Ed). Hematology basic principles and practice (2000), Churchill Livingstone, Philadelphia, Pennsylvania 2096-2097
2. Montgomery R.R., and Scott J.P. Platelet an blood vessel disorders. In: Behrman R.E., Kliegman R.M., and Jenson H.B. (Eds). Nelson textbook of pediatrics, 17th international edition (2004), Saunders, Philadelphia 1670-1674
3. Kuhne T., Buchanan G.R., Zimmerman S., Michaels L.A., Kohan R., Berchtold W., et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 143 5 (2003) 605-608
4. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 4 (2003) 574-596
5. Neau D., Bonnet F., Michaud M., Perel Y., Longy-Boursier M., Ragnaud J.-M., et al. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis 30 2 (1998) 115-118
6. Poullin P., and Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 344 8932 (1994) 1293 [see comments]
7. Ronchi F., Cecchi P., Falcioni F., Marsciani A., Minak G., Muratori G., et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child 78 3 (1998) 273-274
8. Meyboom R.H.B., Fucik H., and Edwards I.R. Thrombocytopenia reported in association with hepatitis B and A vaccines [18]. Lancet 345 8965 (1995) 1638
9. Cummins D., Wilson M.E., Foulger K.J., Dawson D., and Hogarth A.M. Haematological changes associated with influenza vaccination in people aged over 65: case report and prospective study. Clin Lab Haematol 20 5 (1998) 285-287
10. Beeler J., Varricchio F., and Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J 15 1 (1996) 88-90
11. Jadavji T., Scheifele D., and Halperin S. Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J 22 2 (2003) 119-122
12. Al-Bassam A., Al Rabeeah A., Al-Fawaz I., and Al-Samarrai A. Possible pneumococcal vaccine associated thrombocytopenia in a child. Emirates Med J 12 3 (1994) 261-263
13. Citron M.L., and Moss B.M. Pneumococcal-vaccine-induced thrombocytopenia. JAMA 248 10 (1982) 1178
14. Bartos H.R. Thrombocytopenia associated with rubella vaccination. N Y State J Med 72 4 (1972) 499
15. Bachand A.J., Rubenstein J., and Morrison A.N. Thrombocytopenic purpura following live measles vaccine. Am J Dis Child 113 2 (1967) 283-285
16. Kiefaber R.W. Thrombocytopenic purpura after measles vaccination. N Engl J Med 305 4 (1981) 225
17. Sharma O.N. Thrombocytopenia following measles-mumps-rubella vaccination in a one-year-old infant. Clin Pediatr 12 5 (1973) 315
18. Autret E., Jonville-Bera A.P., Galy-Eyraud C., and Hessel L. Thrombocytopenic purpura following measles, mumps and rubella vaccination. Therapie 51 6 (1996) 677-680
19. Chang S.K.Y., Farrell D.L., Dougan K., and Kobayashi B. Acute idiopathic thrombocytopenic purpura following combined vaccination against measles, mumps, and rubella. J Am Board Fam Pract 9 1 (1996) 53-55
20. Azeemuddin S. Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella. Clin Pediatr 26 6 (1987) 318
21. Yenicesu I., and Yetgin S. O[spacing diaeresis]zyu[spacing diaeresis]rek E. Vaccination-associated immune thrombocytopenic purpura in five children. Pediatr Hematol Oncol 18 8 (2001) 547-549
22. Drachtman R.A., Murphy S., and Ettinger L.J. Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization. Arch Pediatr Adolesc Med 148 3 (1994) 326-327
23. Vlacha V., Forman E.N., Miron D., and Peter G. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination. Pediatrics 97 5 (1996) 738-739
24. Nieminen U., Peltola H., Syrjala M.T., Makipernaa A., and Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr 82 3 (1993) 267-270
25. Miller E., Waight P., Farrington P., Andrews N., Stowe J., and Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 84 3 (2001) 227-229
26. Farrington P., Pugh S., Colville A., Flower A., Nash J., Morgan-Capner P., et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345 8949 (1995) 567-569 [see comments]
27. Sharrar R.G., LaRussa P., Galea S.A., Steinberg S.P., Sweet A.R., Keatley R.M., et al. The postmarketing safety profile of varicella vaccine. Vaccine 19 7-8 (2000) 916-923
28. Lee S.Y., Komp D.M., and Andiman W. Thrombocytopenic purpura following varicella-zoster vaccination. Am J Pediatr Hematol-Oncol 8 1 (1986) 78-80
29. Wise R.P., Salive M.E., Braun M.M., Mootrey G.T., Seward J.F., Rider L.G., et al. Postlicensure safety surveillance for varicella vaccine. JAMA 284 (2000) 1271-1279
30. Burke P.J., and Shah N.R. Thrombocytopenic purpura after smallpox vaccine. Pa Med 84 9 (1981) 49-50
31. Nicolopoulos D., Matsaniotis N., Kattamis C., and Athanassiades T. Post-vaccinial complications. Report of 45 cases. Helv Paediatr Acta 24 4 (1969) 378-389
32. Rubin R.H., Hattwick M.A., Jones S., Gregg M.B., and Schwartz V.D. Adverse reactions to duck embryo rabies vaccine. Range and incidence. Ann Intern Med 78 5 (1973) 643-649
33. Kaplan C., Morel-Kopp M.C., Kieny M.P., Kolbe H., Salmon P., Sicard D., et al. Antiplatelet antibodies during the course of HIV-preventive vaccine trial. AIDS 10 4 (1996) 447-449
34. Lepow M.L., Samuelson J.S., and Gordon L.K. Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults. J Infect Dis 150 3 (1984) 402-406
35. Forrest J.M., Honeyman M.C., and Lovric V.A. Rubella vaccination and thrombocytopenia. Aust N Z J Med 4 4 (1974) 352-355
36. Weibel R.E., Neff B.J., Kuter B.J., Guess H.A., Rothenberger C.A., Fitzgerald A.J., et al. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. J Am Med Assoc 254 17 (1985) 2425-2439
37. Oski F.A., and Naiman J.L. Effect of live measles vaccine on the platelet count. N Engl J Med 275 7 (1966) 352-356
38. Benichou C., and Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol 33 (1991) 257-262
39. Davis R.L., Marcuse E., Black S., Shinefield H., Givens B., Schwalbe J., et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the vaccine safety datalink project. Pediatrics 100 5 (1997) 767-771
40. Fescharek R., Quast U., Maass G., Merkle W., and Schwarz S. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects. Vaccine 8 5 (1990) 446-456
41. Rosenthal S., and Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health 85 12 (1995) 1706-1709
42. Stratton K.R., Howe C.J., and Johnston Jr. R.B. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 271 20 (1994) 1602-1605
43. Kratz A., and Lewandrowski K. MGH case records: normal reference laboratory values. N Engl J Med 339 (1998) 1063-1072
44. Cheng C.K., Chan J., Cembrowski G.S., and van Assendelft O.W. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol 10 1 (2004) 42-53
45. Van den Bossche J., Devreese K., Malfait R., Van de Vyvere M., Wauters A., Neeis H., et al. Reference intervals for a complete blood count determined on different automated haematology analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120. Clin Chem Lab Med 40 January (1) (2002) 69-73
46. Giles C. The platelet count and mean platelet volume. Br J Haematol 48 1 (1981) 31-37
47. Ruan C., Wu Y., Okada T., Motoi S., Kondo T., Jiang M., et al. Studies on reference intervals for platelet counts in three cities in China and one in Japan. Thromb Haemost 88 1 (2002) 111-114
48. Lozano M., Narvaez J., Faundez A., Mazzara R., Cid J., Jou J.M., et al. Platelet count and mean platelet volume in the Spanish population. Med Clin (Barc) 110 20 (1998) 774-777
49. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ [last accessed February 9, 2006].
50. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm [last accessed February 9, 2006].
51. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm [last accessed February 9, 2006].
52. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896-1900. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006].
53. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006].